In 1977, with dozens of fires set daily and tourism in freefall, New York hired an artist to save the city. His infamous ...

Merck & Co. Inc. closed 41.34% below its 52-week high of $134.63, which the company achieved on June 25th.

The early consistency of New Yorker art deco covers expressed both wonderful visual ideas and a graphic language for ...

Did the Packers' 'G' logo come before Georgia used it? Does the team have a mascot? Where'd the name come from? We answer those questions and more.

Unite.AI is committed to rigorous editorial standards. We may receive compensation when you click on links to products we review. Please view our affiliate disclosure. Creating a strong brand identity ...

The new logo looks more like the classic black-and-white logo used by HBO for decades. The logo reportedly updated on the streaming service on Sunday morning. Millions will be watching "The White ...

Creator and showrunner Mike White felt "scene was so small and the topic so big" it wasn't worth keeping amidst the heightened political climate. “There was a bit more context to her home life.

The American College of Cardiology and the Association of Black Cardiologists have selected three recipients of the Merck Research Fellowship Award, fostering the next generation of cardiovascular ...

Merck (MRK) released phase III data for an injection form of its blockbuster cancer treatment drug Keytruda and announced the FDA is reviewing the application for approval. The data showed that ...

We help you find the best camera for black and white, whether you want to shoot on digital or film. With years of experience shooting black and white across both film and digital workflows, I’ve ...

NEW YORK, March 27 (Reuters) - Merck & Co (MRK.N), opens new tab said on Thursday that it plans to launch a subcutaneously injected version of its blockbuster cancer immunotherapy Keytruda in the ...

(Reuters) -Merck has signed a licensing agreement for a heart disease drug with Jiangsu Hengrui Pharmaceuticals worth up to $2 billion, the latest in a series of deals U.S. drugmakers have ...